Evaluate COVID-19 symptoms and understand VitAL's next steps. Learn more
woman on phone

Substance Use In Alabama Innovative Care Practice

Free Webinar Series — From July 16 to October 1, 2021

Register for free for one or all webinars by clicking HERE

Description: VitAL presents a webinar series for providers and healthcare professionals in Alabama to gain knowledge and skills on a variety of topics related to substance use disorder (SUD).

Who Should Attend: The webinar series is designed for physicians in all specialties, physician as­sistants, certified registered nurse practitioners, nurse midwives, pharmacists, social workers, RNs, and others who need or wish to increase their knowledge and ability to effectively screen, dialogue, and treat individuals with a SUD.

Statement of Need: The national epidemic of untreated addiction places a heavy burden on the health system of Alabama, as addiction makes it harder to treat other health condi­tions, increases acute-care use and drives up medical costs. Treatment for SUD has historically been delivered outside of primary care; however, there is increasing rec­ognition among government leaders, medical educators, and addiction specialists that specialty facilities alone cannot meet the demand for addiction treatment. Increasing the capacity of providers to deliver SUD treatment or recovery services resulting from the demonstration project is essential in curtailing the SUD epidemic in the future.  The rapid onset and escalation of opioid use has left Alabama unprepared to address the needs of those with addiction. Training opportunities for healthcare professionals to im­prove patient care by maintaining or improving their knowledge, skills and attitudes regarding SUD is paramount. Attendees will also be presented with resources to utilize for the recognition, prevention, treatment, and management of patients with a SUD.

Register for free for one or all webinars below by clicking HERE

Addressing Substance Use Stigma (JULY 16th 1:00 to 2:00 PM) by Jessica Jaiswal, PhD

• Explore the implications of structural inequality in creating and perpetuating stigma.
• Describe various types of stigma affecting people who use drugs and people in substance use treatment.
• Identify strategies that healthcare providers and staff can employ to proactively address stigma.

A Healthcare Worker’s Guide to Effective Telehealth Communication (JULY 22nd 1:00 to 2:00 PM) by Rhiannon Reese, MA, LPC

• Debate the difference of effective communication between a telehealth and in-person visit.
• Examine the value of building a strong relationship during a telehealth visit.
• Assemble the skills required in effective communication during a telehealth visit (nonverbal, reflection, open-ended questions, etc).
• Develop culturally competent strategies of effective communication across different populations (ages, disabilities, LGBTQ, survivors, rural areas, etc).

Bridging the Gap: Telemedicine as a Path to Primary Care Pharmacotherapy (JULY 23rd 1:00 to 2:00 PM) by Holly Russell, MD & Michele Lawrence, MBA, MPH

• Outline a strategy to improve access to pharmacotherapy for OUD using telemedicine.
• Review the care transitions from treatment organizations to the bridge and then back to PCPs as well as the limited scope of the telemedicine practice.
• Provide an overview of the tools that facilitate this approach.

Addiction and the Brain – A New Perspective (JULY 29th 1:00 to 2:00 PM) by Mark Westfall, MD

• Develop a basic understanding of the terminology and definitions used in the substance use field. Terms such as: addiction, psychological dependence, physical dependence, cravings, withdrawals, dual diagnosis, and substance abuse.
• Describe a concept of addictive behavior that includes a neurobiological theory (“incentive sensitization”). This concept will help in the un­derstanding of the human experiences of liking, wanting, repetitive use, and relapse.
• Educate patients regarding this neurobiological theory as part of a nonjudgmental clinical approach. The ultimate goal is to create a pro­vider/patient team in an effort to combat the unintended outcome of destructive addictive behavior.

Opponent Process Theory (JULY 30th 1:00 to 2:00 PM) by Brent Boyett, DMD, DO, DFASAM

• Examine the concept of opioid induced hyperalgesia.
• Discuss the importance of pain and pleasure in the survival of the organism.
• Summarize the concept of hedonic tone and how this relates to addiction and survival.
• Critique why Alabama leads the world in per capita use of prescription opioids.
• Evaluate if Alabama’s chronic pain epidemic is iatrogenic.

“Buprenology” (AUG 13th 1 :00 to 2:00 PM) by Brent Boyett, DMD, DO, DFASA

• Examine the unique properties of buprenorphine.
• Discuss the history of this molecule including how and why it was developed.
• Evaluate how buprenorphine treats the brain to prevent withdrawals and control opioid cravings.

Motivational Interviewing & Boundaries in Treatment (AUG 20th 1 :00 to 2:00 PM) by Mark Westfall, MD

• Develop a basic understanding of the 5 Principles of the Motivational Interviewing technique as it relates to treating patients who present with any of the substance related and addictive disorders.
• Interpret the concept of Boundaries as it relates to human relationships and personal responsibility. This concept will then be utilized in the treatment approach of individuals and families suffering from any substance related and addictive disorder.
• Differentiate the difference between the concepts of “Control” vs “Accountability” vs “Responsibility” and their utilization in their clinical conversations with patients about addiction.

Opioid Use Disorder in Pregnancy (AUG 27th 2:00 to 5:00 PM) by Alta DeRoo, MD

Prenatal (2:00-3:00)

• Examine the effect of Opioid Use Disorder on the developing fetus

Perinatal (3:00-4:00)

• Differentiate the treatment for Opioid Use Disorder in pregnancy – including medications and withdrawal.
• Discuss intrapartum and postpartum care for the mother with opioid use disorder.

Postnatal (4:00-5:00)

• Analyze breastfeeding in the environment of polysubstance substance use disorder.

ACEs and Development of Substance Use Disorder (SEP 10th 1:00 to 2:00 PM) by Stephen Taylor, MD

• List the 1O Adverse Childhood Experiences (ACES) that have been identified and discuss the evidence base for their original identification.
• Discuss the body of research evidence that supports the understanding that ACES are associated with a wide variety of adverse health outcomes, and list some of those outcomes.
• Recognize the “ACE Score Questionnaire” and the dose-response relationship between ACES and the subsequent development of adverse health outcomes.
• Discuss the evidence that points to specifically elevated risk for development of substance use disorder with respect to alcohol, tobacco/nicotine, and prescription medications in people with elevated ACES scores.

Implementing an Integrated Healthcare Approach (SEP 17th 1:00 to 2:00 PM) by Li Li, MD & Shanna McIntosh, MS

• Identify best practices for care.
• Explain the SBIRT Model.
• Discuss the dynamics of integrated healthcare and the needs of the health care team for implementation.
• Recognize the systems that are needed to adopt a tiered service delivery model.
• Discuss the referral process and access to resources.

Evaluation & Treatment of Adolescents with Co-Occurring Opioid Use Disorder and General Psychiatric Illness (SEP 24th 1 :00 to 2:00 PM) by Stephen Taylor, MD

• Briefly discuss some of the epidemiology of adolescent substance use and general psychiatric disorders.
• Provide an evidence-based, clinically-useful definition of addiction, and apply that definition to the opioid-addicted adolescent who may present in the primary care setting.
• Discuss important clinical considerations in evaluating an adolescent for a possible opioid use disorder.
• Discuss effective treatment of adolescents with opioid and other substance use disorders, in light of NIDA’s evidence-based Principles of Drug Addiction Treatment.
• Discuss the updated definition of “MAT” and its role in the treatment of adolescents with opioid use disorder.

Alcohol Use Disorder: Screening and Diagnostic Assessment (SEP 30th 1 :00 to 2:00 PM) by Jacqueline Tulsky, MD

• Describe the national and local prevalence of Alcohol Use Disorder (AUD).
• Provide an overview of current practices surrounding AUD assessment and diagnosis.
• Describe the toolkit for effective counseling and social model-based treatment.
• Discuss the National Substance Use Warmline and how it can support providers.

Alcohol Use Disorder Treatment (OCT 1st 1:00 to 2:00 PM) by Li Li, MD

• Recognize the epidemiology/prevalence of alcohol use disorder, especially during COVID.
• Discuss diagnostic criteria and biomarkers for alcohol use disorder.
• Evaluate pharmacological interventions for alcohol withdrawal and relapse prevention.

CE Provider Statements

This webinar has been approved as a Continuing Education Provider with the Alabama Board of Social Workers and may offer approved clock hours for programs that meet Alabama Board of Social Workers guidelines.

This program is sponsored by the Alabama Pharmacy Association Research and Education Foundation (APAREF).  The Alabama Pharmacy Association Research and Education Foundation is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

RNs will be provided a certificate of attendance to an AMA PRA Category 1 approved activity by The Medical Foundation of Alabama, which can be submitted to the Board of Nursing for credit.

This webinar series is approved by the Alabama Board of Dental Examiners. UAB School of Dentistry designates this activity for 1 hour of continuing dental education credit. Dentists should only claim the credit commensurate with the extent of their participation in the activity. This activity is approved for Dentists only (not dental staff).

Continuing Medical Education

The Medical Foundation of Alabama designates this live activity for a maximum of 15 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of the State of Alabama through the joint providership of the Medical Foundation of Alabama and VitAL. The Medical Foundation of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.


This webinar series is supported by the Centers for Medicare and Medicaid Services (CMS) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $5,160,539 with 70 percentage funded by CMS/HHS and $6000 amount and 30 percentage funded by Project Freedom, a Substance Abuse and Mental Health Services Administration (SAMHSA) grant. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CMS/SAMHSA/HHS, or the U.S. Government.